Dato Capt. Mahesan Subramaniam/LinkedIn
Feb 23, 2026, 17:46
Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
“Anger suppresses the immune system by triggering a ‘fight-or-flight’ response that floods the body with stress hormones like cortisol and adrenaline. While these hormones provide a short-term energy burst, they inhibit the production and activity of critical immune cells.
The physiological impact of anger can be broken down into several key pathways:
- Hormonal Inhibition: Elevated cortisol levels directly suppress the activity of white blood cells, including natural killer (NK) cells and lymphocytes, which are essential for fighting off viruses and abnormalities cells.
- Inflammatory Dysregulation: Anger increases the production of pro-inflammatory cytokine. Over time, this leads to chronic inflammation, which damages tissues and can trigger autoimmune disorders where the immune system attacks it own body.
- Antibody Reduction: Chronic hostility has been linked to a weakened ability to produce antibodies, increasing susceptibility to common infections like the cold or flu.
- Cellular ‘Freeze’ Response: In cases of trauma or suppressed rage, the body may stay in a constant state of alert, causing the immune system to eventually ‘collapse’ or become hyper-reactive.
While just one minute of anger can suppress the immune system, chronic or persistent anger is associated with slower wound healing, higher risks of heart disease, and a greater likelihood of developing autoimmune conditions like rheumatoid arthritis and lupus.”
Discover the latest in Hemostasis Today.
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden